Autoimmune hemolytic anemia complicated with myelodysplastic syndrome in a patient of EBV associated hepatitis: a case report

The human body maintains a delicate balance where the immune system acts as a vigilant defense force, identifying and neutralizing foreign invaders like bacteria and viruses while leaving the body's own healthy cells untouched. Sometimes, this system malfunctions, turning its weapons against the very cells it is meant to protect. One such condition is autoimmune hemolytic anemia, a disorder where the immune system mistakenly creates antibodies that attack and destroy red blood cells, leading to severe anemia and fatigue. While this condition can occur on its own, it is sometimes linked to other serious blood disorders or infections, creating a complex medical puzzle where doctors must determine which problem is causing the other, or if they are fueling each other. Understanding these rare connections is vital because the treatment for one condition might differ entirely from another, and missing the underlying cause can lead to rapid deterioration.

In a recent case report from the 900th Hospital of PLA Joint Logistic Support Force, medical researchers documented the challenging journey of a seventy-one-year-old man who arrived at the hospital suffering from diarrhea, abdominal pain, extreme fatigue, and difficulty breathing. Upon examination, the patient presented with a pale complexion and a distinct yellow tint to his skin, signs of severe anemia and jaundice. Initial blood tests revealed a critical drop in his red blood cell count and hemoglobin levels, alongside a low platelet count, while his white blood cell count remained normal. Further investigation showed that his urine contained protein and bilirubin, and his blood contained a significant number of immature cells known as blasts. These early signs pointed toward a breakdown in the body's blood production system, but the full picture required a deeper look into the bone marrow, the spongy tissue inside bones where blood cells are made.

When doctors examined a sample of the patient's bone marrow, they found a chaotic scene that confirmed a diagnosis of myelodysplastic syndrome, specifically a subtype known as RAEB2. This condition is characterized by the production of defective blood cells that do not mature properly. The marrow was filled with abnormal cells, including small and misshapen megakaryocytes, which are the large cells responsible for making platelets, and a high percentage of immature blasts. The presence of these malformed cells, along with specific markers found during microscopic analysis, solidified the diagnosis of this blood disorder. However, the patient's condition was not driven by a single factor. Tests also revealed a massive amount of Epstein-Barr virus DNA in his system, indicating an active infection that was damaging his liver and contributing to his overall decline.

The complexity of this case lay in the interplay between the blood disorder, the viral infection, and the immune system's self-attack. The patient's red blood cells were coated with antibodies, a finding confirmed by a positive Coombs test, which is the hallmark of autoimmune hemolytic anemia. This meant his immune system was actively destroying his red blood cells, a process accelerated by the underlying myelodysplastic syndrome and the presence of the Epstein-Barr virus. While the patient's younger brother had died of leukemia, suggesting a possible family history of blood issues, the researchers could not confirm a specific genetic cause in this case. The medical team also considered whether the patient had a different condition called Evans syndrome, which involves both low platelets and low red blood cells due to autoimmunity, but the specific pattern of his bone marrow and the exclusion of other causes made the diagnosis of myelodysplastic syndrome with autoimmune hemolytic anemia the most accurate fit.

Despite receiving supportive care for five days, the patient's condition worsened, characterized by repeated fevers, pulmonary and intestinal infections, and liver, renal, respiratory, and heart failure. The combination of the blood disorder, the viral hepatitis, and the immune system's attack on his own cells proved too much for his body to withstand, and he was discharged automatically. The researchers noted that while autoimmune complications are known to occur in patients with blood cancers, the specific combination of autoimmune hemolytic anemia and myelodysplastic syndrome in the context of an Epstein-Barr virus infection is extremely rare. The case highlights how a viral infection can trigger or worsen immune dysfunction, leading to a cascade of failures in the blood system.

This report serves as a crucial reminder for medical professionals that when a patient presents with jaundice, anemia, and low platelets, especially if they have a history of blood disorders, doctors must look beyond the surface symptoms. The presence of autoantibodies should be tested for promptly to distinguish between different causes of blood cell destruction. In this instance, the patient's condition was likely driven by a synergy between the myelodysplastic syndrome and the Epstein-Barr virus, creating a perfect storm that overwhelmed his immune system. By documenting this rare occurrence, the authors hope to improve the speed and accuracy of diagnosis for future patients, ensuring that the complex relationship between viral infections, blood disorders, and autoimmune attacks is recognized early enough to potentially prevent a hemolytic crisis.